Variant report
Variant | nsv975610 |
---|---|
Chromosome Location | chr12:86635438-86639126 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:86633057..86634931-chr12:86636880..86638760,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs148260207 | chr12:86635609-86635610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73396190 | chr12:86635631-86635632 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs150815281 | chr12:86635649-86635650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs9651932 | chr12:86635654-86635655 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs527412048 | chr12:86635662-86635663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs548924141 | chr12:86635679-86635680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs113616064 | chr12:86635698-86635699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs566927559 | chr12:86635700-86635701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs140000531 | chr12:86635727-86635728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76533637 | chr12:86635739-86635740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574739308 | chr12:86635740-86635741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs145426759 | chr12:86635846-86635847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1493420 | chr12:86635847-86635848 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs182284884 | chr12:86635898-86635899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs138364897 | chr12:86635920-86635921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534034472 | chr12:86635933-86635934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs114322428 | chr12:86635996-86635997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12318124 | chr12:86636031-86636032 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs111769619 | chr12:86636032-86636033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs572821375 | chr12:86636045-86636046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs12423847 | chr12:86636066-86636067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376771205 | chr12:86636104-86636105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs147308137 | chr12:86636108-86636109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs17013842 | chr12:86636115-86636116 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs545156301 | chr12:86636161-86636162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs560100170 | chr12:86636191-86636192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:86635600-86636200 | Enhancers | Placenta Amnion | Placenta Amnion |